US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 891.680
  • +46.370+5.49%
Close Aug 9 16:00 ET
  • 892.320
  • +0.640+0.07%
Post 20:01 ET
847.48BMarket Cap109.81P/E (TTM)

Eli Lilly and Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
35.98%11.3B
25.98%8.77B
19.56%34.12B
28.10%9.35B
36.84%9.5B
28.11%8.31B
-10.88%6.96B
0.79%28.54B
-8.73%7.3B
2.49%6.94B
Operating revenue
35.98%11.3B
25.98%8.77B
19.56%34.12B
28.10%9.35B
36.84%9.5B
28.11%8.31B
-10.88%6.96B
0.79%28.54B
-8.73%7.3B
2.49%6.94B
Cost of revenue
20.07%2.17B
2.88%1.67B
6.82%7.08B
15.50%1.79B
17.79%1.86B
26.35%1.81B
-21.50%1.63B
-9.34%6.63B
-24.49%1.55B
10.36%1.58B
Gross profit
40.40%9.13B
33.02%7.09B
23.41%27.04B
31.49%7.57B
42.44%7.64B
28.61%6.5B
-7.05%5.33B
4.31%21.91B
-3.29%5.75B
0.38%5.36B
Operating expense
13.15%4.71B
20.46%4.36B
22.60%16.25B
23.24%4.03B
23.29%4.21B
25.77%4.17B
17.69%3.62B
1.42%13.26B
-4.43%3.27B
6.43%3.42B
Selling and administrative expenses
10.67%2B
12.41%1.84B
14.40%6.94B
15.15%1.46B
11.75%1.8B
18.23%1.81B
11.53%1.63B
-1.21%6.07B
-16.39%1.27B
7.23%1.61B
-General and administrative expense
10.67%2B
12.41%1.84B
14.40%6.94B
15.15%1.46B
11.75%1.8B
18.23%1.81B
11.53%1.63B
-1.21%6.07B
-16.39%1.27B
7.23%1.61B
Research and development costs
15.05%2.71B
27.09%2.52B
29.52%9.31B
28.40%2.56B
33.62%2.41B
32.25%2.36B
23.29%1.99B
3.75%7.19B
5.14%2B
5.72%1.8B
Operating profit
88.95%4.42B
59.53%2.74B
24.66%10.79B
42.31%3.54B
76.08%3.43B
34.02%2.34B
-35.61%1.71B
9.08%8.65B
-1.76%2.49B
-8.73%1.95B
Net non-operating interest income expense
-96.90%-146.3M
-95.04%-133.8M
-16.18%-312.3M
-60.17%-93.7M
-23.29%-75.7M
-4.65%-74.3M
11.94%-68.6M
14.50%-268.8M
20.95%-58.5M
19.84%-61.4M
Non-operating interest income
-18.91%37.3M
33.92%45.8M
176.43%173.6M
74.51%44.5M
143.28%48.9M
350.98%46M
388.57%34.2M
147.24%62.8M
244.59%25.5M
187.14%20.1M
Non-operating interest expense
52.62%183.6M
74.71%179.6M
46.53%485.9M
64.52%138.2M
52.88%124.6M
48.15%120.3M
21.08%102.8M
-2.41%331.6M
3.19%84M
-2.51%81.5M
Other net income (expense)
-330.94%-755M
43.61%-65.7M
-148.43%-3.92B
-181.87%-937.5M
-817.61%-2.92B
69.94%-175.2M
78.09%-116.5M
-7.86%-1.58B
46.19%-332.6M
60.65%-318.5M
Gain on sale of security
-143.30%-157.9M
216.79%16M
95.08%-20.2M
-52.78%121.3M
48.99%-62.9M
45.42%-64.9M
96.78%-13.7M
-332.17%-410.7M
375.64%256.9M
50.04%-123.3M
Special income (charges)
-506.90%-589.3M
-5.24%-110.5M
-235.40%-3.87B
-148.13%-690.3M
-1,006.40%-2.98B
77.95%-97.1M
36.59%-105M
31.83%-1.15B
48.69%-278.2M
53.86%-268.9M
-Less：Restructuring and merger&acquisition
----
----
97.83%45.5M
----
----
----
----
76.92%23M
----
----
-Less:Impairment of capital assets
--435M
----
----
----
--0
--0
----
----
----
--206.5M
-Less:Other special charges
58.91%154.3M
5.24%110.5M
318.25%3.8B
159.31%622.6M
4,667.79%2.98B
-77.95%97.1M
-36.59%105M
-33.94%908.5M
-45.15%240.1M
-89.29%62.4M
-Write off
----
----
-89.98%22.2M
----
----
----
----
-26.89%221.6M
----
----
Other non- operating income (expenses)
40.91%-7.8M
1,209.09%28.8M
-128.67%-32.7M
-18.37%-368.5M
56.58%115.4M
44.07%-13.2M
-96.29%2.2M
-127.82%-14.3M
-1,899.42%-311.3M
266.67%73.7M
Income before tax
68.38%3.52B
65.79%2.54B
-3.70%6.55B
19.67%2.51B
-72.71%427.2M
91.48%2.09B
-25.51%1.53B
10.57%6.81B
13.94%2.1B
25.71%1.57B
Income tax
68.93%550.2M
58.66%293.2M
134.01%1.31B
101.07%319.1M
325.83%484.6M
135.33%325.7M
22.63%184.8M
-2.13%561.6M
39.46%158.7M
-15.83%113.8M
Net income
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
30.77%1.45B
Net income continuous Operations
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
30.77%1.45B
Minority interest income
Net income attributable to the parent company
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
30.77%1.45B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
30.77%1.45B
Basic earnings per share
67.86%3.29
67.11%2.49
-16.02%5.82
19.38%2.4346
-103.73%-0.06
84.91%1.96
-29.38%1.49
12.68%6.93
12.67%2.0393
31.97%1.61
Diluted earnings per share
68.21%3.28
66.44%2.48
-15.94%5.8
18.67%2.42
-103.73%-0.06
85.71%1.95
-29.05%1.49
12.75%6.9
12.67%2.0393
31.97%1.61
Dividend per share
15.04%1.3
15.04%1.3
15.31%4.52
15.31%1.13
15.31%1.13
15.31%1.13
15.31%1.13
15.29%3.92
15.29%0.98
15.29%0.98
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 35.98%11.3B25.98%8.77B19.56%34.12B28.10%9.35B36.84%9.5B28.11%8.31B-10.88%6.96B0.79%28.54B-8.73%7.3B2.49%6.94B
Operating revenue 35.98%11.3B25.98%8.77B19.56%34.12B28.10%9.35B36.84%9.5B28.11%8.31B-10.88%6.96B0.79%28.54B-8.73%7.3B2.49%6.94B
Cost of revenue 20.07%2.17B2.88%1.67B6.82%7.08B15.50%1.79B17.79%1.86B26.35%1.81B-21.50%1.63B-9.34%6.63B-24.49%1.55B10.36%1.58B
Gross profit 40.40%9.13B33.02%7.09B23.41%27.04B31.49%7.57B42.44%7.64B28.61%6.5B-7.05%5.33B4.31%21.91B-3.29%5.75B0.38%5.36B
Operating expense 13.15%4.71B20.46%4.36B22.60%16.25B23.24%4.03B23.29%4.21B25.77%4.17B17.69%3.62B1.42%13.26B-4.43%3.27B6.43%3.42B
Selling and administrative expenses 10.67%2B12.41%1.84B14.40%6.94B15.15%1.46B11.75%1.8B18.23%1.81B11.53%1.63B-1.21%6.07B-16.39%1.27B7.23%1.61B
-General and administrative expense 10.67%2B12.41%1.84B14.40%6.94B15.15%1.46B11.75%1.8B18.23%1.81B11.53%1.63B-1.21%6.07B-16.39%1.27B7.23%1.61B
Research and development costs 15.05%2.71B27.09%2.52B29.52%9.31B28.40%2.56B33.62%2.41B32.25%2.36B23.29%1.99B3.75%7.19B5.14%2B5.72%1.8B
Operating profit 88.95%4.42B59.53%2.74B24.66%10.79B42.31%3.54B76.08%3.43B34.02%2.34B-35.61%1.71B9.08%8.65B-1.76%2.49B-8.73%1.95B
Net non-operating interest income expense -96.90%-146.3M-95.04%-133.8M-16.18%-312.3M-60.17%-93.7M-23.29%-75.7M-4.65%-74.3M11.94%-68.6M14.50%-268.8M20.95%-58.5M19.84%-61.4M
Non-operating interest income -18.91%37.3M33.92%45.8M176.43%173.6M74.51%44.5M143.28%48.9M350.98%46M388.57%34.2M147.24%62.8M244.59%25.5M187.14%20.1M
Non-operating interest expense 52.62%183.6M74.71%179.6M46.53%485.9M64.52%138.2M52.88%124.6M48.15%120.3M21.08%102.8M-2.41%331.6M3.19%84M-2.51%81.5M
Other net income (expense) -330.94%-755M43.61%-65.7M-148.43%-3.92B-181.87%-937.5M-817.61%-2.92B69.94%-175.2M78.09%-116.5M-7.86%-1.58B46.19%-332.6M60.65%-318.5M
Gain on sale of security -143.30%-157.9M216.79%16M95.08%-20.2M-52.78%121.3M48.99%-62.9M45.42%-64.9M96.78%-13.7M-332.17%-410.7M375.64%256.9M50.04%-123.3M
Special income (charges) -506.90%-589.3M-5.24%-110.5M-235.40%-3.87B-148.13%-690.3M-1,006.40%-2.98B77.95%-97.1M36.59%-105M31.83%-1.15B48.69%-278.2M53.86%-268.9M
-Less：Restructuring and merger&acquisition --------97.83%45.5M----------------76.92%23M--------
-Less:Impairment of capital assets --435M--------------0--0--------------206.5M
-Less:Other special charges 58.91%154.3M5.24%110.5M318.25%3.8B159.31%622.6M4,667.79%2.98B-77.95%97.1M-36.59%105M-33.94%908.5M-45.15%240.1M-89.29%62.4M
-Write off ---------89.98%22.2M-----------------26.89%221.6M--------
Other non- operating income (expenses) 40.91%-7.8M1,209.09%28.8M-128.67%-32.7M-18.37%-368.5M56.58%115.4M44.07%-13.2M-96.29%2.2M-127.82%-14.3M-1,899.42%-311.3M266.67%73.7M
Income before tax 68.38%3.52B65.79%2.54B-3.70%6.55B19.67%2.51B-72.71%427.2M91.48%2.09B-25.51%1.53B10.57%6.81B13.94%2.1B25.71%1.57B
Income tax 68.93%550.2M58.66%293.2M134.01%1.31B101.07%319.1M325.83%484.6M135.33%325.7M22.63%184.8M-2.13%561.6M39.46%158.7M-15.83%113.8M
Net income 68.27%2.97B66.77%2.24B-16.08%5.24B13.01%2.19B-103.95%-57.4M85.11%1.76B-29.32%1.34B11.88%6.24B12.26%1.94B30.77%1.45B
Net income continuous Operations 68.27%2.97B66.77%2.24B-16.08%5.24B13.01%2.19B-103.95%-57.4M85.11%1.76B-29.32%1.34B11.88%6.24B12.26%1.94B30.77%1.45B
Minority interest income
Net income attributable to the parent company 68.27%2.97B66.77%2.24B-16.08%5.24B13.01%2.19B-103.95%-57.4M85.11%1.76B-29.32%1.34B11.88%6.24B12.26%1.94B30.77%1.45B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 68.27%2.97B66.77%2.24B-16.08%5.24B13.01%2.19B-103.95%-57.4M85.11%1.76B-29.32%1.34B11.88%6.24B12.26%1.94B30.77%1.45B
Basic earnings per share 67.86%3.2967.11%2.49-16.02%5.8219.38%2.4346-103.73%-0.0684.91%1.96-29.38%1.4912.68%6.9312.67%2.039331.97%1.61
Diluted earnings per share 68.21%3.2866.44%2.48-15.94%5.818.67%2.42-103.73%-0.0685.71%1.95-29.05%1.4912.75%6.912.67%2.039331.97%1.61
Dividend per share 15.04%1.315.04%1.315.31%4.5215.31%1.1315.31%1.1315.31%1.1315.31%1.1315.29%3.9215.29%0.9815.29%0.98
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Weight Loss Drugs
Weight Loss Drugs
Intraday+3.80%
Donald Trump
Donald Trump
Intraday+0.95%